E. Jeffes

发表

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study.

J. Nelson, E. Jeffes, J. Mccullough, 1997, Archives of dermatology.

Recombinant human cytokines stimulate neutrophil adherence to IgG autoantibody-treated epithelial basement membranes.

E. Jeffes, W. Gammon, J. D. Hendrix, 1990, The Journal of investigative dermatology.

Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate.

M. Pittelkow, E. Jeffes, J. Mccullough, 1995, The Journal of investigative dermatology.

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.

E. Jeffes, E. Jeffes, G. Weinstein, 2001, Journal of the American Academy of Dermatology.

Levulan ® : the first approved topical photosensitizer for the treatment of actinic keratosis

E. Jeffes, 2002, The Journal of dermatological treatment.

Cytotoxic and immunologic effects of methotrexate in psoriasis.

E. Jeffes, G. Weinstein, J. Mccullough, 1990, The Journal of investigative dermatology.

Methotrexate and other chemotherapeutic agents used to treat psoriasis.

E. Jeffes, G. Weinstein, 1995, Dermatologic clinics.

Etanercept as prophylactic psoriatic therapy before interferon‐α and ribavirin treatment for active hepatitis C infection

E. Jeffes, J. Wu, D. Fife, 2010, Clinical and experimental dermatology.

PHOTODYNAMIC THERAPY OF ACTINIC KERATOSES WITH TOPICAL 5-AMINO-LEVULINIC ACID (ALA) AND VISIBLE RED-LIGHT (630-NM)

E. Jeffes, J. Mccullough, W. Hoffman, 1994 .